Dymicron has announced that it has appointed Gunther Peeters as Senior Vice President of Commercial Operations. With more than 15 years of spine industry experience, he will lead all aspects of international commercialization, including sales, market development and logistics.
“We are very pleased to have Gunther join our leadership team,” said Alan Layton Chairman and CEO of Dymicron. “As we advance our commercial activities in key international markets, Gunther’s expertise in cervical arthroplasty and extensive network of relationships in the spine industry will help us achieve our commercial goals and support our strategic initiatives.”
Gunther Peeters brings experience in managing sales, commercial and clinical business development with spinal technologies. He subsequently served as Vice President of the European business for Vexim prior to an acquisition of Vexim by Stryker in 2017.
Most recently, he served as Vice President, International Market Development for Mainstay Medical. He co-owns a distribution and 3PL provider of innovative technology for cardiology and vascular surgery in Belgium and Luxembourg, named Bryonix.
